High PLK1 expression is a common feature in numerous cancer types (39–45), and elevated PLK1 levels have been linked to aggressive tumor traits, including TNBC, vascular invasion, high proliferation rates, and poor prognostic implications in BC (46, 47). Here, PLK1 is linked to breast cancer.